Olanzapine Versus An Active Comparator in the Treatment of Schizophrenia

PHASE4CompletedINTERVENTIONAL
Enrollment

530

Participants

Timeline

Start Date

August 31, 2001

Study Completion Date

July 31, 2002

Conditions
Schizophrenia
Interventions
DRUG

Olanzapine

Trial Locations (60)

Unknown

El Centro

Glendale

Sherman Oaks

Middleton

Norwich

Melbourne

Miami

Atlanta

Chicago

Hoffman Estates

Lafayette

Rockville

Newton

Saint Charles

New York

Olean

Staten Island

Cincinnati

Portland

Philadelphia

Austin

El Paso

Houston

Terrell

Richmond

La Plata

Godoy Cruz

Buenos Aires

Ciudad de Buenos Air

Graz

Innsbruck

Linz

Wein

Wels

Salvador

Aparecida de Goiânia

Pelotas

Sau Paulo

Rio de Janeiro

Essen

Hamburg

Tübingen

Dublin

Mexico City

Lima

Cidra

Ponce

Rio Piedras

San Juan

Barcelona

San Boi de Llobregat

Elizondo

Pamplona

Langreo

Camberwell

London

Kings Lynn

Paisley

Guildford

Caracas

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT00036088 - Olanzapine Versus An Active Comparator in the Treatment of Schizophrenia | Biotech Hunter | Biotech Hunter